Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Equity Ratio (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Equity Ratio for 6 consecutive years, with 0.86 as the latest value for Q3 2021.

  • Quarterly Equity Ratio rose 38.1% to 0.86 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was 0.86 through Sep 2021, up 38.1% year-over-year, with the annual reading at 0.82 for FY2020, 23.3% up from the prior year.
  • Equity Ratio for Q3 2021 was 0.86 at ENDRA Life Sciences, down from 0.87 in the prior quarter.
  • The five-year high for Equity Ratio was 0.98 in Q2 2017, with the low at 2.53 in Q1 2017.
  • Average Equity Ratio over 5 years is 0.51, with a median of 0.77 recorded in 2018.
  • The sharpest move saw Equity Ratio tumbled 136.96% in 2018, then surged 209.53% in 2019.
  • Over 5 years, Equity Ratio stood at 0.86 in 2017, then grew by 0.42% to 0.87 in 2018, then dropped by 23.31% to 0.66 in 2019, then grew by 23.3% to 0.82 in 2020, then grew by 5.03% to 0.86 in 2021.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.86, 0.87, and 0.94 for Q3 2021, Q2 2021, and Q1 2021 respectively.